These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37449209)

  • 21. DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.
    Shang Z; Wang Z; Zhang Y; Liu S
    Transl Cancer Res; 2023 Oct; 12(10):2781-2805. PubMed ID: 37969400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair-associated signature.
    Zhang P; Wen B; Gong J; Liu Z; Zhang M; Zhou G; Zhang L; Zhang Z
    Environ Toxicol; 2024 May; 39(5):2803-2816. PubMed ID: 38287713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a 15 DNA Damage Repair-Related Gene Signature as a Prognostic Predictor for Lung Adenocarcinoma.
    Gu L; Xu Y; Jian H
    Comb Chem High Throughput Screen; 2022; 25(9):1437-1449. PubMed ID: 34279196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
    Liang L; Mai S; Mai G; Chen Y; Liu L
    Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing.
    Zhao F; Hong J; Zhou G; Huang T; Lin Z; Zhang Y; Liang L; Tang H
    Front Immunol; 2024; 15():1434450. PubMed ID: 39224598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer.
    Lin Y; Zhang R; Pan H; Li Y
    Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 31. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
    Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma.
    Qin C; Fan X; Sai X; Yin B; Zhou S; Addeo A; Bian T; Yu H
    J Thorac Dis; 2023 Dec; 15(12):6928-6945. PubMed ID: 38249902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
    Sun D; Yang KS; Chen JL; Wang ZB
    World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.
    Chen Y; Huang M; Zhu J; Xu L; Cheng W; Lu X; Yan F
    Front Pharmacol; 2022; 13():857060. PubMed ID: 35496321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.